NCT00071214View on ClinicalTrials.gov

Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

3,600

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

September 30, 2005

Conditions
Staphylococcal InfectionsKidney Failure, Chronic
Interventions
BIOLOGICAL

S. aureus Type 5 and 8 Capsular Polysaccharide Conjugate Vaccine

Sponsors
All Listed Sponsors
lead

Nabi Biopharmaceuticals

INDUSTRY

NCT00071214 - Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis | Biotech Hunter | Biotech Hunter